PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
09-Aug-2022 6-Hour Virtual Seminar on The Use of Drug Master Files & Quality Agreements: Understanding and Meeting your Regulatory and Processing Responsibilities - ResearchAndMarkets.com Businesswire
09-Aug-2022 Akanda to Supply Cansativa with Premium Indoor Cannabis Flower Grown at its Sintra Facility in Portugal Businesswire
09-Aug-2022 AdaptHealth Reports Second Quarter 2022 Results Businesswire
09-Aug-2022 ADC Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates Businesswire
09-Aug-2022 Epizyme Reports Second Quarter 2022 Financial Results and Provides Business Update Businesswire
09-Aug-2022 TransMed7, LLC Announces First Clinical Use of SpeedBird™ Breast Biopsy Devices for Commercial Launch Businesswire
09-Aug-2022 Global Food Allergen Testing Market 2022-2028: High Growth of Global Food Trade & Stringent Government Regulations Driving Sector - ResearchAndMarkets.com Businesswire
09-Aug-2022 2 Day Virtual Seminar: Risk Management of Raw Materials in a GMP Environment (August 29-30, 2022) - ResearchAndMarkets.com Businesswire
09-Aug-2022 La Comisión Europea aprueba IMBRUVICA® (ibrutinib) en un régimen de combinación de duración fija para pacientes adultos con leucemia linfocítica crónica (LLC) sin tratamiento previo Businesswire
09-Aug-2022 La Commission européenne approuve IMBRUVICA® (ibrutinib) en association à durée fixe pour les patients adultes atteints de leucémie lymphoïde chronique (LLC) précédemment non traitée Businesswire
09-Aug-2022 Europäische Kommission erteilt Zulassung für IMBRUVICA® (ibrutinib) als Kombinationspräparat mit fester Behandlungsdauer für erwachsene Patienten mit zuvor unbehandelter chronischer lymphatischer Leukämie (CLL) Businesswire
09-Aug-2022 Full Day Virtual Seminar on Fundamentals of Pharmacokinetics - ResearchAndMarkets.com Businesswire
09-Aug-2022 Full Day Virtual Seminar on Fundamentals of Toxicology - ResearchAndMarkets.com Businesswire
09-Aug-2022 BeiGene Announces Positive Global Phase 3 Trial Results for PD-1 Inhibitor Tislelizumab in First-Line Unresectable Hepatocellular Cancer Businesswire
09-Aug-2022 AFFLINK Grows Leadership Team Businesswire
09-Aug-2022 Biodesix Named a Top 100 Healthcare Technology Company of 2022 Businesswire
09-Aug-2022 North America Bioanalytical Testing Services Market Report 2022: Rising Demand for Analytical Testing of Biologics and Biosimilars & Increasing Preference for Outsourcing Driving Growth - ResearchAndMarkets.com Businesswire
09-Aug-2022 Germany Cold Chain Logistics Market Report 2022: Pharmaceutical Industry Demand for Advanced Cold-Chain Services Driving Growth - ResearchAndMarkets.com Businesswire
09-Aug-2022 Dravet Syndrome Treatment Market Report 2022-2029: Stiripentol and Cannabidiol to Contribute to Significant Growth of 11.7% - ResearchAndMarkets.com Businesswire
09-Aug-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire